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Abstract
Background: Patient safety is an ongoing global priority, with medication safety considered a prevalent, high-risk area 
of concern. Yet, we have little understanding of the supports and barriers to safe medication management in the 
Canadian home care environment. There is a clear need to engage the providers and recipients of care in studying and 
improving medication safety with collaborative approaches to exploring the nature and safety of medication 
management in home care.
Methods: A socio-ecological perspective on health and health systems drives our iterative qualitative study on 
medication safety with elderly home care clients, family members and other informal caregivers, and home care 
providers. As we purposively sample across four Canadian provinces: Alberta (AB), Ontario (ON), Quebec (QC) and Nova 
Scotia (NS), we will collect textual and visual data through home-based interviews, participant-led photo walkabouts of 
the home, and photo elicitation sessions at clients' kitchen tables. Using successive rounds of interpretive description 
and human factors engineering analyses, we will generate robust descriptions of managing medication at home 
within each provincial sample and across the four-province group. We will validate our initial interpretations through 
photo elicitation focus groups with home care providers in each province to develop a refined description of the 
phenomenon that can inform future decision-making, quality improvement efforts, and research.
Discussion: The application of interpretive and human factors lenses to the visual and textual data is expected to yield 
findings that advance our understanding of the issues, challenges, and risk-mitigating strategies related to medication 
safety in home care. The images are powerful knowledge translation tools for sharing what we learn with participants, 
decision makers, other healthcare audiences, and the public. In addition, participants engage in knowledge exchange 
throughout the study with the use of participatory data collection methods.
Background
Patient safety is an ongoing health system priority glob-
ally, with medication safety earmarked as a prevalent,
high-risk area of concern [1-4]. Maintaining medication
safety depends upon the integrity of a complex series of
interrelated steps, with failures in assessment, prescrip-
tion, dispensing, and monitoring potentially leading to
adverse events and harm. Human beings and the systems
we create are fallible, and at present, we have little under-
standing of the supports and barriers to safe medication
management in the home care environment for clients,
family members, or healthcare providers. Compromised
medication management can be extremely costly to
patients, healthcare professionals, and the healthcare sys-
tem [4-10]. A recent report concluded that approximately
1.5 million preventable adverse drug events occur per
year, resulting in a total cost of $3.5 billion [11]. Similarly,
as many as one in five Canadian patients admitted to hos-
pital suffered adverse events within three weeks after
being discharge home; 66% of these were medication-
related events [12-14]. Moreover, patients recognize
problems with the manner in which medications are pro-
vided to them. In the 2002 Commonwealth Fund Survey,
11% of patients in Canada reported that they had been
given the wrong medication at one time or another [15].
Patients for patient safety is one important initiative of
the World Alliance for Patient Safety established in 2004
whereby patients and/or their advocates are making
themselves knowledgeable about patient safety initiatives,
* Correspondence: patricia.marck@ualberta.ca
1 Faculty of Nursing, University of Alberta, Clinical Research Unit, Royal 
Alexandra Hospital, Alberta Health Services, 6-10 University Terrace, 8303 - 112 
Street, Edmonton, AB, T6G 2T4, Canada
Full list of author information is available at the end of the articleMarck et al. Implementation Science 2010, 5:43
http://www.implementationscience.com/content/5/1/43
Page 2 of 9
working to inform the public, and participating interna-
tionally in the development of safety initiatives [16].
There is a clear need to engage the providers and recipi-
ents of care in studying and improving medication safety,
and our study contributes to that agenda by adopting a
collaborative approach to exploring the nature and safety
of medication management for chronically ill seniors
receiving home care services.
Overview of literature: Medication safety for seniors 
receiving home care
This study addresses a critical gap in our current under-
standing of medication safety for seniors within the
Canadian home care sector. The elderly often manage
more than one chronic illness, a complex palate of medi-
cations, along with other care needs. The total annual
cost of preventable drug-related morbidity (PDRM) in
Canada's seniors was estimated to be $11 billion in 2000
[ 7 ] .  A  r e c e n t  s t u d y  o b s e r v e d  t h a t  a s  m a n y  a s  1  i n  1 1
seniors in Halifax, Nova Scotia experienced a PDRM over
a two-year period [17]. Many of these lapses in safety
occur in clients' homes. However, medication safety
research to date has focused overwhelmingly on institu-
tional settings that may have little applicability to the
home care environment. For instance, most healthcare
that takes place in private homes, which are not designed
for such activities, is provided by unregulated workers,
family, and unpaid caregivers [18]. There is also increas-
ing recognition that traditional methods for classifying
drug-related problems including categories such as 'drug
without indication,' 'indication without drug,' 'wrong
drug,' and 'wrong dose' [19] are not sufficient and practi-
cal for home care [20]. For example, social, economic,
and community issues are critical when medication-
related problems are being assessed. Such issues include:
whether the client can afford medication and transporta-
tion to fill the prescription; confusion about the purpose,
dose, or timing of the medications; and living with an
overwhelmed caregiver who has their own health con-
cerns.
Caring for elderly individuals with chronic illnesses in
their homes is inherently complex. There has been an
increase in t he medicaliza tion of priva t e homes, st em-
ming from higher set thresholds for hospitalization, as
well as patient acuity at discharge and transfer across care
sectors [21]. With the advent of mobile technology (i.e.,
peritoneal and haemodialysis, long term intravenous
catheters and oxygen/inhalation therapy) 'hospital at
home' services have seen a huge increase [22]. When pro-
viding home care services, it is necessary to consider all
factors, including the physical environment, family
dynamics, and the cognitive and physical abilities of the
client and caregivers. Caregivers, often elderly, are con-
tending with their own health challenges and can lack
sleep as they provide care almost 24 hours per day. In
contrast, within the institutional scenario there are two or
three shifts per day of professionals who provide care.
Family members and caregivers often feel a sense of
responsibility to attempt to keep the client at home, with-
out fully appreciating that this objective may be unattain-
able or unrealistic [23,24].
Providers collaborate with clients, families, and their
unpaid caregivers to mitigate risks, but the nature of
home environments requires clients and caregivers to
regularly exercise autonomous decision making about
medication use in the context of minimal professional
supervision as well as frequently strained or absent home
and community supports [18]. In addition, the challenges
of documentation and communication, which are height-
ened at points of transfer across sectors [12-14,25], also
increase the potential for inadequate medication recon-
ciliation and its attendant risks. Moreover, the vulnerabil-
ity of home care staff working predominantly without the
proximal supervisory support of colleagues, and the
uniqueness of each home setting cannot be overlooked
[18,26]. Thus, the care and safety of clients around medi-
cation management cannot be attended to without
including the family members, unpaid caregivers, and
paid providers in the equation [27-29].
Guiding theoretical framework: a socio-ecological 
perspective
Our perspective is that the unique nature of private
homes and communities as well as the multiple inter-
relationships among clients, family, unpaid caregivers,
and home care staff constitutes a complex socio-ecologi-
cal phenomenon in terms of safe medication manage-
ment. A socio-ecological perspective addresses the
influences of social, emotional, functional, and physical
contexts of safety pertaining to medication management
in home care. Socio-ecological thinking provides a frame-
work for understanding the diverse personal and environ-
mental factors and the interrelationships amongst them,
which influence a given health situation [30,31]. Implicit
in this perspective on health is the idea that relationships
between humans and their environment are reciprocal
[30-34]. Many concepts from systems theory are incorpo-
rated into this approach in order to elucidate this
dynamic relationship [31,35]. Another premise of an eco-
logical perspective is that humans in environments may
be described at several levels of aggregation: individual,
family, organization, community, and population [34].
Following from this premise is the necessity of both
describing the multiple levels of determinants of a prob-
lem and identifying opportunities for integrated action
across these levels.
Research questions
The purpose of our research is to understand medication
management within the socio-ecological complexity ofMarck et al. Implementation Science 2010, 5:43
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the Canadian home care environment. Our research
questions are:
1. What medication management issues do seniors with
chronic illness, their family members, caregivers, and
paid providers identify within publicly funded home care
programs in four Canadian provinces (Alberta, Ontario,
Quebec, and Nova Scotia)?
2. What socio-ecological factors contribute to or
reduce the risks of medication management in the home
for seniors with chronic illness, their family members,
caregivers, and providers in these four Canadian prov-
inces?
3. What strategies do seniors with chronic illness, their
family members, caregivers, and paid providers employ
to mitigate the risks of medication management at home
in the these four Canadian provinces?
4. How do the medication management issues, relevant
socio-ecological factors, and mitigation strategies that are
identified compare across these four provincial home
care programs?
By applying a broad socio-ecological lens to the phe-
nomenon of medication safety in the home, we expect to:
illustrate the breadth and depth of risks that seniors, their
family members/caregivers, and providers currently
encounter in terms of medication management; illumi-
nate the supports and strategies that seniors, their family
members/caregivers, and providers presently use to miti-
gate those risks; and identify potential areas for reducing
risks and improving health system supports for medica-
tion management in the home.
Methods/research design
Setting and sampling strategy
This study takes place concurrently across four Canadian
provinces: Alberta (AB), Ontario (ON), Quebec (QC) and
Nova Scotia (NS). Purposive and theoretical sampling
will be used. Purposive sampling entails deliberatively
selecting participants according to the needs of the study
[36]. Theoretical sampling will be used once emerging
categories related to medication management safety are
identified in the initial stages of data analysis in order to
direct further sampling to obtain the fullest possible
explanation of these categories [36-38]. To ensure maxi-
mum variation in this sample, efforts to include seniors of
different genders, ages, and home situations will be made.
Sampling will continue and be directed by evolving pat-
t e r n s  a n d  i n s i g h t s  g a i n ed  f r o m  t h e  d a t a.  T h i s  f o r m  o f
sampling [39] will allow us to verify newly developed pat-
terns, explore relationships among them, and extend our
analyses.
In each of the four provinces, we will sample approxi-
mately eight households with a chronically ill senior
receiving home care services for greater than three
months at the time of enrolment in the study. In each
household, family member(s) and/or caregiver(s), along
with the case manager and paid provider(s) (total approx-
imately three to four participants per household) will be
invited to participate in in-depth interviews, providing a
potential total of 32 interviews/province or 128 inter-
views across the four provinces. We will also purposefully
sample some clients who experienced a transfer across
sectors (i.e., hospitalization and/or ER visit) within the
past 90 days of enrolment in the study to obtain insights
regarding medication reconciliation and continuity of
care as the community dwellers intersect with the acute
care sector.
Theoretic sampling based on iterative phases of data
collection and analysis poses challenges to predicting the
precise number of participants that should be included in
the study at the outset of the research. Based on the itera-
tive analysis process in interpretive description (ID)
[37,40,41], we acknowledge that we may not have uncov-
ered all patterns relevant to medication safety in home
care in each province at 32 interviews. In order to
approximate this goal, we will also track outliers in the
data. Outliers or rare instances of something will then be
considered in the context of identified patterns, and rela-
tionships among patterns, to theorize how they may con-
tribute. Selection of arbitrary sample numbers, analyzing
the data, and theorizing outliers are deemed in an ID
approach to produce findings with clinical relevance, yet
do not profess to have uncovered all that is relevant to an
issue as does the claim of achieving saturation [40].
Eligibility criteria
All participants will be able to speak and understand
either English or French. Clients will be 65 years of age or
older, legally competent, have at least one chronic condi-
tion, and be a recipient of home care services, ideally have
at least one family member living with them, and have an
identified unpaid caregiver. Family and caregiver partici-
pants must be at least 18 years of age and legally compe-
tent. Paid providers will have worked in home care for a
minimum of one year.
Terminology
It is important to distinguish the terminology used in this
proposal. The term 'caregivers' refers to family members
or friends, who are in an unpaid role but often are
responsible for or charged with caring for the client. Fam-
ily member(s) are individual(s) identified by the client
and/or caregiver as being close to the client through
blood, legal, or emotional ties, and who may or may not
reside in the same home as the identified client. Providers
are the professionals or non-professionals, regulated or
unregulated, who are employed by organizations provid-
ing home care services (i.e., case managers, nurses, aides,
pharmacists, and therapists).Marck et al. Implementation Science 2010, 5:43
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Methodology and methods
Our qualitative research design incorporates the method-
ological perspectives of ID and human factors analysis
(HFA) into successive, iterative phases of visual and tex-
tual data collection and data analysis, using a suite of par-
ticipatory photographic research methods to illuminate
the experiences of clients, caregivers, and home care pro-
viders with managing medication in the home from a
variety of vantage points.
Interpretive description
The three central methodological elements of an ID
research approach are the objective, the mechanisms, and
the product. In this study, the methodological objective is
to develop a credible conceptual explanation of the phe-
nomenon of medication management safety at home. The
mechanisms used to attain this objective are: identifying
and exploring multiple relevant sources of visual and tex-
tual data; understanding and comparing across several
sources of data, synthesizing the data to capture mean-
ings, constructing theoretical relationships from the data,
and explaining the theoretical relationships in ways that
are meaningful and applicable in home care. The product
of this type of research approach is a theoretical explana-
tion about what is common within the phenomenon
under study across participants and their particular con-
texts [37,41]. The characteristics, patterns, and structure
of the phenomena are conceptualized in order to arrive at
the explanation.
The theoretical assumptions that underpin ID method-
ology are that the researcher and participants interact
and influence one another in the generation of the data;
the experiences of the participants and the researcher are
socially constructed and context dependent; and the
product or the explanation emerges and is grounded in
the data [37,40,41]. These assumptions are congruent
with a social ecological framework that seeks to under-
stand the reciprocal relationship between humans and
their environment and at various levels of aggregation. ID
also calls for the use of multiple methods of data collec-
tion, and as such it is particularly suited to this study,
which will employ interviews, household photographic
walkabouts, and photo narration with clients and caregiv-
ers, kitchen table talks using photo elicitation with cli-
ents, caregivers and healthcare providers, and photo
elicitation focus groups with providers. Generating data
through multiple methods enables the researchers to test
insights that emerge from the use of one method with the
findings that are generated through the application of
other methods [37,41].
Human factors analysis
Human factors (HF) engineering is a scientific discipline
that specializes in understanding how humans interact
with the world around them. It draws upon applied
research in a variety of areas to define the parameters and
constraints that influence human behavior in order to
design efficient human-centered processes to improve
reliability and safety [42]. Healthcare providers vary
greatly in their abilities. Lay people, who increasingly rep-
resent a growing proportion of caregivers, demonstrate
even more variability. The performance and safety profile
of the care they provide are often compromised by noise,
poor lighting, heat, dirt, improper cleaning products, and
moisture. Stress and fatigue, in addition to a lack of prep-
aration and education to manage an array of medications,
can also degrade performance over time. A caregiver's
performance is directly influenced by the operating char-
acteristics and conditions of the equipment, and the envi-
ronment and processes involved in medication
management. User interfaces that are complex, mislead-
ing, or illogical can induce errors in even the most skilled
users.
HFA is needed to help health service providers broaden
their analyses of medication management safety and to
develop more effective and lasting remedies to mitigate
the risks to all involved [43], regardless of where the ser-
vices are provided (i.e., home, community, or institution-
alized setting). Throughout the study, focusing on
supports and barriers to safe medication management,
the HF research team members will examine visual and
textual data that:
1. provide a general, preliminary assessment of the
home care environment (e.g., low lighting, bright lighting,
quiet, loud, hot, cold, many stairs, carpets, hardwood,
open concept, narrow hallways, number of stories, pres-
ence of outside to inside staircase, ramp, et al.).
2. illustrate devices, technology, systems/processes
related to care (e.g., a white board to keep track of medi-
cations), physical features of the home environment (e.g.,
stairs), and devices/materials as they are located in the
home environment (e.g., where medications are kept and
how they are stored).
Participatory photographic research methods
The collection and analysis of visual images offers a more
comprehensive understanding of the complexity of medi-
cation management in the home setting. The photo-
graphic research methods we will use include:
1. Client and caregiver walkabouts of the home to col-
lect photos that they narrate in relation to the phenome-
non.
2. Subsequent kitchen table talks with clients, caregiv-
ers, and healthcare providers using interview data, walk-
about photos, and walkabout photo narratives to elicit
further discussion of safety supports and issues.
3. Photo elicitation focus groups with additional groups
of healthcare providers to deepen the analysis of manag-
ing medication safety in the home.Marck et al. Implementation Science 2010, 5:43
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Related forms of participatory photo narration where
participants collect or lead the collection of images to tell
stories about the phenomenon under study have been
successfully employed in studies of falls prevention with
seniors [44] and in medication safety research conducted
in the hospital setting [30]. To extend our understanding
of the broader context influencing medication manage-
m e n t ,  w e  w i l l  t h e n  r e v i e w  t h e  p h o t o s  d u r i n g  k i t c h e n -
table talks [45] in the client's home with their family,
caregivers, and providers in order to elicit further data
from them about their experiences of managing medica-
tions in the home. In addition, we will conduct focus
groups with regulated providers (i.e., nurses, pharma-
cists, physicians, physio-therapists, et al.) and non-regu-
lated healthcare aides and homemakers, using select
photos and quotes from the visual and textual data to
elicit discussion about the challenges surrounding medi-
cation management in home care and will validate
researcher interpretations of the data gathered during
initial in-depth interviews, photo walkabout narratives,
and kitchen-table talks.
Participant recruitment
The research assistant (RA) will work with the case man-
agers from the participating organizations (i.e., Alberta
Health Services, VON Canada in Ontario and Nova Sco-
tia, and the Centre for Social and Health Services Caven-
dish in Quebec) to help identify and recruit participants.
Case managers will briefly describe the study to the client
and family/caregivers, in person or by phone, and ask
permission to release their name to the researcher. Dur-
ing the initial contact with the case manager, potential
participants will be reassured that accepting to release
their names to the RA will not obligate them to partici-
pate in the study. Those who agree will be contacted by
the RA who will explain the study in greater detail,
answer any relevant questions, and establish verbal con-
sent for those who are expected to participate. All partici-
pants will sign formal consent forms prior to each
interview.
With the exception of the client, who will be inter-
viewed in his or her home, other interviewees will be
interviewed at a time and location convenient to them.
The researchers recognize that there are topics that may
be sensitive, confidential, and/or private in nature and
that participants may prefer not to share information in
the presence of other participants (especially related to:
potential abuse, fatigue, frustration, et al.). Should the
family member(s) and/or caregiver(s) prefer to be inter-
viewed in the client's home the interviewer will make
efforts to help select a physical space that will ensure
maximum possible privacy for the interviewees. Potential
provider participants will receive a summary of the proj-
ect and whom they should contact regarding their partic-
ipation in the interview and/or focus groups.
Phases of iterative data collection and analysis
At the onset and throughout the research, the provincial
study leads in each province will engage in periodic
immersion in the field to supervise data collection and to
gain familiarity with the emerging issues. Consistent with
the theoretical underpinnings of ID, three successive
phases of data collection and analysis will be directed in a
concurrent, iterative fashion [37,41] as follows:
Phase A - component one
Audio-taped, in-depth, semi-structured interviews will
be conducted in an approximate total of 32 households
(eight households across four provinces) with three to
four participants per household (one client, one or two
family/caregiver(s), one case manager, and one or two
provider(s). This interview component will be conducted
by a study lead and a trained research assistant with the
support of two tools:
1. Semi-structured interview guide designed to facili-
tate dialogue with the participants about their respective
views of medication management in the context of home
care.
2. Checklist of HF probes that incorporates a prelimi-
nary HF assessment of the client and their home situation
from each participant's perspective--e.g., is the client
hard of hearing? Does the client have vision loss? Does
the client use a wheelchair? How are medications stored?
This will provide some context related to everyday life in
that household. If relevant HF topics do not emerge dur-
ing the initial stages of the interview, the checklist will
help the researchers include these topics in the discus-
sion.
Phase A - component two
Audio-taped photo narrated walkabouts will be con-
ducted in the homes of the clients. Adapting from photo
narration methods and field protocols used in previous
safety research in the community [44] and acute care [30],
we will conduct audio-taped client and family caregiver-
led walkabouts of client participants' homes during the
same initial home visit for interviews. In a select number
of Ontario households, a human factors engineer (HFE)
co-investigator will accompany the study lead and RA to
assess the home environment for medication manage-
ment from a HF perspective. During these walkabouts,
participants will verbally narrate and visually guide the
study lead and RA through their day-to-day experience of
managing medication safety. The research assistant and
HFE, when present, will participate in observational anal-
yses during these walkabouts. The RA will also collect
still digital photographs of areas of the home that partici-Marck et al. Implementation Science 2010, 5:43
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pants identify as significant to managing medication
safety. Semi-structured questions and a list of prompts
will be used to seek and audio-record the client's and/or
caregiver's perspectives on the emotional, social, func-
tional, economic, physical, and environmental challenges
that they encounter as they try to manage medication
safely as well as the coping strategies that they use to
identify and mitigate risks. Permission will be sought to
take additional photographs in the event the RA or HFE
identify noteworthy areas.
The interview data collected will be assigned file num-
bers, backed up, professionally transcribed, and then
u p l o a d e d  i n t o  p a s s w o r d  p r o t e c t e d  M S  W o r d  f i l e s  f o r
hand analysis purposes as well as into text files in NVivo8
[46]. As interview transcripts and field notes become
available, members of the research team will first inde-
pendently read and reflexively annotate the transcripts/
field notes several times and then provide their respective
preliminary coding of the transcripts they have reviewed
to the RAs to enter into NVivo8. The strategy of using
two or more people to independently code and analyze
the data and using other team members to code and ana-
lyze a sub-set of data is an example of a successful analy-
sis strategy employed in previous studies [47]. Using the
data management capabilities of NVivo8, team members
will then subsequently convene to identify recurring,
converging, and opposing patterns, relationships among
patterns, illustrative examples, linkages to theory, prac-
tice, and policy, as well as issues for further group deliber-
ation.
The RAs will upload, back up, and store the photo-
graphic data (jpeg files) and the transcribed photo narra-
tion data and field notes that we collect in component
two walkabouts into NVivo8 in accordance with previ-
ously used research procedures [44]. We will then repeat
a version of the phase A - component one process where
team members first independently and concurrently ana-
lyze and code the visual and written texts and then collec-
tively re-analyze the visual and written data in NVivo8.
This part of the analysis will include evaluating photos of
specific medication management strategies in the home
environments using principles of socio-ecological theory
and HF (such as usability heuristics) to objectively iden-
tify latent safety issues [48]. Examples of heuristics
include consistency, visibility, efficiency, flexibility, and
error prevention.
To identify areas of similarity and difference among cli-
ents, family members, caregivers, providers, as well as
a c r o s s  h o m e  c a r e  s e r v i c e  d e l i v e r y  m o d e l s  i n  t h e  f o u r
provinces, the team will then conduct coding compari-
sons to identify coding discrepancies. Coding compari-
sons enrich the analysis by including aggregate data,
multiple interpretations, and cross-referencing [49]. Dis-
crepancies in coding will lead to the development of new
coding categories and define areas for further explora-
tion. As the volume of data increases, is reviewed, re-
reviewed, and then coded, categories will be revised and
refined in an iterative process among the research team
members. As exemplars from coded categories are
retrieved and compared within and across the written
and visual text for the initial walkabouts, we will incorpo-
rate questions about the categories that emerge into sub-
sequent interviews with remaining walkabout
participants in order to expand findings and check
descriptive and interpretive credibility [37,50]. We will
also track outliers in the data set.
Following the piloting of data collection and data analy-
sis for components one and two with two households in
Ontario by one study lead, an RA, and a HFE, we will
review and modify the data collection tools for compo-
nents one and two as indicated. Additional initial home
visits (components one and two) and subsequent home
kitchen table talks (component three) will then be con-
ducted with households as participants are recruited in
each of the four provinces, using an iterative approach to
data analysis within each case and across cases as we pro-
ceed in the four provinces. The provincial research teams
will meet every two to three weeks throughout data col-
lection and analysis to allow for ongoing iterative com-
parison of emerging patterns and relationships in their
respective data sets, and to theorize about respective out-
liers.
Phase B - component three
Based on the data analyses that we generate in phase A,
we will design and conduct three audio-recorded kitchen
table talks per province with two to four participants per
household. During these kitchen table talks, the RA will
review selected photos of the client's home with the client
and at least one to two other caregiver(s) and/or pro-
vider(s) in order to observe them and their inter-rela-
tional dynamics [45] in the setting where services are
delivered, and to elicit and stimulate group discussion
and further narrative accounts of medication safety and
concerns regarding medication management from the
various discussants' perspectives.
We will then repeat a third round of independent analy-
ses of the visual and textual data followed by a collective
team analysis in NVivo8 to arrive at our preliminary find-
ings about the data from the first two phases of the
research. When the pan-Canadian team can demonstrate
a robust, credible interpretation of the data from phases
A and B across all four provinces, phase C will be initiated
in all of the provinces to conduct the fourth component
of data collection, photo elicitation focus groups, to trian-
gulate with the household data and strengthen the credi-
bility of the analytic process.Marck et al. Implementation Science 2010, 5:43
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Phase C - component four
To assess the confirmability of the findings from the first
two phases of iterative data collection and analyses, the
study leads will conduct two audio-taped focus groups
with home care providers in each province. One focus
group will be conducted with six to eight regulated pro-
viders and one with six to eight unregulated providers. A
total of eight focus groups will be conducted across all
provinces. Using selected photographic data and our
evolving interpretive and HF analyses, we will elicit pro-
viders' perceptions of risks and supports related to medi-
cation management safety in home care. Each focus
group will last a maximum of two hours. These providers
will not be asked to directly recount their experiences
with one specific case, but rather asked to provide infor-
mation to enrich the findings to date from the first three
components by describing and discussing their experi-
ences in general around medication management in
home care. Field notes will be recorded after each focus
group.
Initially, phase C focus group transcripts with accom-
panying field notes will be independently analyzed by the
study leads for each province. Study leads and HF team
members will then jointly analyze the transcripts to
derive a multi-dimensional narrative of medication man-
agement in the home from the perspectives of the client,
caregiver, and/or family member, and paid provider. It is
also important to note that the focus groups will also
serve an important knowledge translation opportunity in
this study, because the home care providers are acting as
participants and stakeholders in this research, they also
become a vehicle for knowledge dissemination.
Throughout all phases of data collection, the RAs, HFE,
and other investigators will enhance the visual and verbal
data that is collected by recording field notes using a stan-
dardized template. The study leads and research team
members will also assign planned periods of data analysis
bet wee n ea c h s t ep du ring  t he  da ta c oll ect io n phase  t o
ensure adequate integration and synthesis of data into the
next step of the research, with the study leads maintain-
ing and sharing ongoing notes about the emerging analy-
ses and syntheses with the full research team for
feedback. Interim analyses will be shared with the whole
research team for feedback and critique to enhance the
rigor of emerging interpretations of the data. This step-
wise analysis will continually inform research decisions
about sampling and guide supplemental modifications to
protocols at each step. For example, congruent with the
iterative process of ID, as data collection and preliminary
analysis progress, we will modify successive protocols for
the interviews, walkabouts, kitchen table talks, and focus
groups in light of emerging themes in order to seek fur-
ther insights, test preliminary findings, and look for com-
monalities and/or differences among participants.
Scientific integrity
The research has received ethical review and approval
from the participating universities and service providers
(McGill University, University of Ottawa, Dalhousie Uni-
versity, University of Alberta, VON Canada, CSSS Caven-
dish, and CSSS Bordeaux-Cartier-Ville St-Laurent).
Written informed consent will be obtained from all par-
ticipants and confidentiality will be assured and pre-
served in all cases. The study has relied on strong
communication and interdisciplinary collaboration from
conception to realization. In addition to bi-weekly meet-
ings held between the provincial study leads (AL, MM,
and PM), the research team has utilized several different
forms of communication to navigate operational issues
with all collaborators. Through the co-principal investi-
gator at the University of Alberta, the team has access to a
web-based login system, E-Class, in which drafts of cur-
rent papers, ethics proposals, and protocols can be easily
shared between all members of team. Additionally,
through E-Class, the research team can meet virtually
and use screen sharing to collaborate on documents in
real-time. All collaborators are kept up-to-date with
quarterly e-newsletters.
The rigor of the interpretations that are developed in
this study is strengthened by input at varying stages from
research team members with expertise in one or more of
nursing, medicine, pharmacy, HF engineering, healthcare
ethics, law, patient advocacy, healthcare administration,
home care practice, and qualitative and visual methods.
Attention to rigor will be reflected by openly accounting
for the impact of bias (personal, discipline/profession-
based, et al.) on study results, recording clear documen-
tation about the research-gathering contexts and proce-
dures, and creating a logically auditable path from data
collection to conclusion phases [49,51]. The research
team will also optimize the trustworthiness of the study
findings by means of the following measures; credibility,
transferability, dependability, and confirmability [51,52].
Credibility means that the processes used to carry out
the inquiry are made explicit and the findings are
a p p r o v e d  b y  t h e  c o n s t r u c t o r s .  I n  t h i s  s t u d y ,  w e  w i l l
achieve credibility by immersing ourselves in the data to
come up with tentative explanatory notions that are then
subjected to peer scrutiny and returned to the co-con-
structors of the explanations through the kitchen table
talks, providing a test of the researcher's interpretations.
A further test of credibility has been incorporated into
this study through consultation at various stages of data
analysis with an advisory panel of experts in the delivery
of home care services who are also part of the Canadian
Patient Safety Institute's (CPSI) Core Team for Safety in
Home Care.
Transferability addresses the question as to whether or
not the study findings are applicable in settings otherMarck et al. Implementation Science 2010, 5:43
http://www.implementationscience.com/content/5/1/43
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than those studied. In order to enhance transferability, we
have thoroughly described our methods and will pay par-
ticular attention in the writing of our findings to describe
in detail the conceptual path we follow to arrive at our
explanations. If this process is adequately described,
those reading the findings will be able to make decisions
about the transferability of the findings of this study to
other settings.
Dependability is assured by demonstrating that a sec-
ond researcher following the same methods and pro-
cesses as the first will uncover similar findings. This study
is ideally structured to meet this criterion with research-
ers collecting data independently in four provinces. Each
researcher will collect and analyze data for their respec-
tive province with ongoing access to the expertise of the
HFE before any cross-province comparisons are made.
This format assures that we will meet the criterion of
dependability.
Confirmability is established when there is agreement
among the researchers that the knowledge generated is
meaningful to clients and care providers as well as being
applicable in the home care setting. Confirmability will
be arrived at by assuring credibility, transferability, and
dependability.
Discussion
This project is original, timely, and pertinent, given the
recent national initiative highlighting the urgency to
advance our understanding of the issues, challenges, and
risk-mitigating strategies related to safety in home care,
particularly around medication management. It high-
lights the need to view safety through a new lens in order
to attend to the complexity, multidimensionality, and dis-
tinctness of safety in home care as compared to patient
safety in institutions while addressing the importance of
continuity across the continuum of care. Consideration of
HF principles contributes unique and diverse perspec-
tives to the research findings, and the use of ID, with a
variety of methods of data collection procedures, brings a
fitting and rich approach to the research question. Fur-
thermore, strong and strategic links with decision- and
policy-makers as co-investigator and collaborators from
the project's inception, including provincial health minis-
tries, national health information, patient safety, and
accreditation bodies, and provincial and federal funding
partners optimizes feasibility and knowledge translation
capacities. An additional strength stems from engaging
participants in knowledge translation throughout the
study with the use of participatory data collection meth-
ods. The shared interaction and influence between the
researchers and participants will generate data and pro-
duce findings that are meaningful and useful to the par-
ticipants and to all stakeholders.
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